Skip to content

Study to evaluate the efficacy of Khadirsaradichurna in the management of Shwitra (vitiligo).

An exploratory study to evaluate the efficacy of Khadirsaradichurnam in the management of Shwitra(vitiligo). - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/081634
Enrollment
40
Registered
2025-03-04
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

None listed

Sponsors

Post graduate institute of ayurveda jodhpur Dr SR Rajasthan ayurved university jodhpur rajasthan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a) Patients having signs and symptoms Mainly Twak-Vaivarnya (skin depigmentation) will select for the present study. b)Patients diagnosed as Shwitra based on clinical features mentioned in Ayurvedic texts c)Assessment according to VASI SCORE d) Sex-either sex. e) Patients who are between 20-60 years will be selected. f) Patient willing to sign the consent form. g) Patient should be capable of obeying Pathya apathya.

Exclusion criteria

Exclusion criteria: a)Patient suffering from vitiligo for more than 1 year. b) Children with Albinism (congenital lack of melanin) were excluded. c) White non-sensational spots,which are characteristic of leprosy. d) Any systemic disease.ex-Cardiovascular disease, Daibetes mellitusetc. e) Any adverse reaction with treatment. f) White spots by trauma and burns. g) Vitiligo patches complicated by eczema.h) Patients with long-term steroid and cytotoxic treatment. i) Patients with evidence of malignancy j) Patient below the age of 20 years and above 60 years.

Design outcomes

Primary

MeasureTime frame
An Exploratory Study To Evaluate The Efficacy Of Khadirsaradichurnam In The Management Of Shwitra (Vitiligo).Timepoint: At baseline,15th day,30th day, 45th day and 60th day.

Secondary

MeasureTime frame
1. A clinical study will be done on Shwitra(vitiligo) 2. Pathogenesis & management with time-tested on the basis of the Ayurvedic principles of disease will be discussed. 3. There will be Single group of patients for the study. 4. To evaluate the adverse drug reaction of a trial drug.Timepoint: At baseline,15th day,30th day, 45th day & 60th day.

Countries

India

Contacts

Public ContactDrSUNITA DANGI

Post gradution institute of ayurveda jodhpur rajasthan

drpramodmishra4@gmail.com9001009793

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026